Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lo

Showing results (121-130 of 236) with videos related to

Pageof 24
Sort By:
Hepatology (Baltimore, Md.)|February 5, 2021
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use DisordersHaesuk Park, Xinyi Jiang, Hyun Jin Song, et al.
Journal of Viral Hepatitis|June 6, 2020
Determinants of stigma among patients with hepatitis C virus infectionM Elle Saine, Julia E Szymczak, Tyler M Moore, et al.
Journal of General Internal Medicine|October 6, 2020
Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting AntiviralsAlbert Do, Denise A Esserman, Supriya Krishnan, et al.
Journal of General Internal Medicine|April 29, 2020
Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting AntiviralsAlbert Do, Denise A Esserman, Supriya Krishnan, et al.
European Journal of Clinical Pharmacology|October 28, 2016
Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)Kirsten J Lum, Craig W Newcomb, Jason A Roy, et al.
Open Forum Infectious Diseases|July 7, 2018
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort StudyCharitha Gowda, Stephen Lott, Matthew Grigorian, et al.
The Journal of Infectious Diseases|September 23, 2006
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppressionRobert Gross, Benita Yip, Vincent Lo Re, et al.
Plos One|February 6, 2020
Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infectionM Elle Saine, Tyler M Moore, Julia E Szymczak, et al.
AIDS (London, England)|July 18, 2022
Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapySarah Vakili, Bam Paneru, Cleandre M Guerrier, et al.
Journal of the American Geriatrics Society|February 14, 2023
Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medicationsKathleen M Akgün, Supriya Krishnan, Janet Tate, et al.
Pageof 24

Showing results (121-130 of 236) with videos related to

Sort By:
Pageof 24
Hepatology (Baltimore, Md.)|February 5, 2021
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use DisordersHaesuk Park, Xinyi Jiang, Hyun Jin Song, et al.
Journal of Viral Hepatitis|June 6, 2020
Determinants of stigma among patients with hepatitis C virus infectionM Elle Saine, Julia E Szymczak, Tyler M Moore, et al.
Journal of General Internal Medicine|October 6, 2020
Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting AntiviralsAlbert Do, Denise A Esserman, Supriya Krishnan, et al.
Journal of General Internal Medicine|April 29, 2020
Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting AntiviralsAlbert Do, Denise A Esserman, Supriya Krishnan, et al.
European Journal of Clinical Pharmacology|October 28, 2016
Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)Kirsten J Lum, Craig W Newcomb, Jason A Roy, et al.
Open Forum Infectious Diseases|July 7, 2018
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort StudyCharitha Gowda, Stephen Lott, Matthew Grigorian, et al.
The Journal of Infectious Diseases|September 23, 2006
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppressionRobert Gross, Benita Yip, Vincent Lo Re, et al.
Plos One|February 6, 2020
Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infectionM Elle Saine, Tyler M Moore, Julia E Szymczak, et al.
AIDS (London, England)|July 18, 2022
Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapySarah Vakili, Bam Paneru, Cleandre M Guerrier, et al.
Journal of the American Geriatrics Society|February 14, 2023
Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medicationsKathleen M Akgün, Supriya Krishnan, Janet Tate, et al.
Pageof 24